Povorcitinib
Drug timelines are a Plus or Pro feature.
15 regulatory and trial events tracked for Povorcitinib, covering 2024-07-03 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis (STOP-PN2) [Phase 3]